-+ 0.00%
-+ 0.00%
-+ 0.00%

NOVARTIS CEO - IF IMPACT ON US BUSINESS TOO HIGH REGARDING MFN, WILL CONSIDER LAUNCHING DRUGS IN PRIVATE MARKETS IN EUROPE

Reuters·10/27/2026 07:07:13